CD4 and melanoma: Some immune suppressor cells (CD8+ T cells, Tfh cells, activated memory CD4+ T cells and M1 macrophages) were found to be correlated with favorable clinical outcomes, but resting memory CD4+ T cells and resting mast cells showed negative associations with prognosis across cancers and in melanoma and urothelial cancer.